USPTO serial 79286967
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $2,600
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Duane M. Byers
Duane M. Byers Nixon & Vanderhye PC901 N. Glebe Road, 11th FloorArlington, VA 22203UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Concentrated pharmaceutical products for hemodialysis treatment, packaged in drums and containers, and diluted products for hemodialysis treatment; pharmaceutical products for hemodialysis and other treatments packaged in flexible bags or glass ampoules, especially solid solutes such as glucose for rehydration and calorie intake; glycocol as a solution for irrigation of blood; mannitol as a solution for irrigation of blood; pharmaceutical preparation, namely, glucose/NaCl mix, for rehydration; pharmaceutical preparation, namely, Ringer's lactate solution for hydroelectric rebalance, hypovolemia, maintaining acid-base balance; pharmaceutical preparation, namely, sodium chloride for rehydration and hydroelectric rebalance, water for injection (WFI) for injectable preparations in the nature of irrigation solution for irrigation of blood; pharmaceutical preparation, namely, generic medical preparations, in the nature of ciprofloxacin as an antibiotic; pharmaceutical preparation, namely, fluconazole as an antifungal, ketoprofen as an analgesic and anti-inflammatory; pharmaceutical preparation, namely, levobupivacaine as an anesthetic; pharmaceutical preparation, namely, levofloxacin as an antibiotic; pharmaceutical preparation, namely, metronidazole as an antibiotic and antiparasitic; pharmaceutical preparation, namely, morphine hydrochloride as an analgesic; pharmaceutical preparation, namely, moxifloxacin as an antibiotic; pharmaceutical preparation, namely, ofloxacin as an antibiotic; pharmaceutical preparation, namely, paracetamol as an analgesic and antipyretic, ropivacaine Hcl as an anaesthetic; pharmaceutical preparation, namely, tirofiban as an anticoagulant; pharmaceutical preparation, namely, zoledronic acid for patients suffering from osteoporosis; pharmaceutical preparation, namely, injectable ampoules containing medicated preparations, namely, quinine as an antimalarial, potassium chloride for hypokalemia, hydroelectric rebalancing; pharmaceutical preparation, namely, sodium chloride for hydroelectric rebalancing; pharmaceutical preparation, namely, water for injection (WFI) as a vehicle for parenteral administration; pharmaceutical preparation, namely, magnesium sulfate for hypokalemia, eclampsia, torsade de pointe, hypocalcemia; pharmaceutical preparation, namely, sodium bicarbonate for metabolic acidosis, cardiovascular arrest; pharmaceutical preparation, namely, glucose for carbohydrate calorie intake | ACTIVE | — |
| 006 | Prefabricated buildings of metal and prefabricated modular metal structures for creating premises for installation of manufacturing units for drugs, concentrated products for hemodialysis treatment and care premises for hemodialysis treatment provided to patients suffering from kidney disorders | ACTIVE | — |
| 009 | Data processing equipment and computers for use in the medical field; data processing equipment and data processing machines for use in the medical field | ACTIVE | — |
| 010 | Hemodialysis machines; control instruments and apparatus in the medical field, namely, controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus; measuring or testing instruments and machines in the medical field, namely, wearable monitors used to measure biometric data for medical use, and blood testing apparatus | ACTIVE | — |
| 011 | Waste disposal incinerators; clean rooms; clean-room installations; apparatus and machines for purifying air and water in the medical field; devices for cooling air and water in the medical field, namely, water coolers, evaporative air coolers, and air conditioning apparatus | ACTIVE | — |
| 037 | Installation, maintenance and repair of installations, equipment and apparatus in the medical field, namely, Hemodialysis machines, control instruments and apparatus in the medical field, namely, controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus, measuring or testing instruments and machines in the medical field, namely, wearable monitors used to measure biometric data for medical use, and blood testing apparatus; installation of clean room systems | ACTIVE | — |
| 041 | Educational and training services, namely providing classes, seminars, workshops, teaching, and distance learning in the medical fields, namely in the field of hemodialysis; vocational retraining in the medical field; personalized coaching as a training service and as an educational service in the medical field; information relating to education; training for staff development, team building and organizational development in the medical field | ACTIVE | — |
| 042 | Technical scientific research and manufacturing project studies in the medical field; technical scientific research and manufacturing project studies and scientific research projects in the medical field; technical scientific research and manufacturing project planning; quality control of products and services in the medical field | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 11, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 13, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 17, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 25, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 28, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 27, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 11, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 11, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 19, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jan 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 19, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 19, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 19, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 19, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 20, 2020 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 9, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 24, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 15, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 12, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 9, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |